8 Alzheimers Disease Clinical Trials in Torrance, CA (2026)

Q: How do I join a clinical trial in Torrance?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you.

Recruiting Alzheimers Disease Studies in Torrance

NCT06256588Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)...

Torrance, CAPHASE3864 participantsGlaxoSmithKline

View Study Details

NCT06937229Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline ...

Torrance, CAPHASE3650 participantsBristol-Myers Squibb

View Study Details

NCT07011732Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease....

Torrance, CAPHASE3426 participantsBristol-Myers Squibb

View Study Details

NCT06567743Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer....

Torrance, CAPHASE2325 participantsCG Oncology, Inc.

View Study Details

NCT06833073Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread...

Torrance, CAPHASE2308 participantsMerck Sharp & Dohme LLC

View Study Details

NCT04142437Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

In this observational study researcher want to learn more about the effectiveness of drug VITRAKVI (generic name: larotrectinib) and how well the drug is tolerated during routine use in patients with ...

Torrance, CA150 participantsBayer

View Study Details

NCT05951179Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

TARA-002-101-Ph2 is an open-label study to investigate the safety and anti-tumor activity of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1...

Torrance, CAPHASE2131 participantsProtara Therapeutics

View Study Details

NCT06005740Recruiting

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-4-500 in patients with advanced cancer. For Part 1, any advanced or metastatic solid...

Torrance, CAPHASE170 participantsTORL Biotherapeutics, LLC

View Study Details

About Alzheimers Disease Clinical Trials in Torrance

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 8 alzheimers disease clinical trials recruiting participants in Torrance, CA. These studies are seeking a combined 2,924 participants. Research is being sponsored by GlaxoSmithKline, Bristol-Myers Squibb, CG Oncology, Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Torrance — FAQ

Are there alzheimers disease clinical trials in Torrance?

Yes, there are 8 alzheimers disease clinical trials currently recruiting in Torrance, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Torrance?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.

Are clinical trials in Torrance free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 8 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 18, 2026 from ClinicalTrials.gov